3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide

C109H106F3N25O8 — CID 159174326

IUPAC3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide
SMILESCc1nc(C(F)(F)F)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)o1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCCCC3)cc2[nH]1)c1ccccc1-c1ccccc1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccccc1NCc1ccccc1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ncccc1Nc1ccccc1
InChIInChI=1S/C30H30N6O2.C30H29N5O.C28H27N7O2.C21H20F3N7O3/c37-30(23-8-4-5-9-25(23)32-17-21-6-2-1-3-7-21)35-28-19-31-18-24(28)29-33-26-11-10-22(16-27(26)34-29)20-36-12-14-38-15-13-36;36-30(24-12-6-5-11-23(24)22-9-3-1-4-10-22)34-28-19-31-18-25(28)29-32-26-14-13-21(17-27(26)33-29)20-35-15-7-2-8-16-35;36-28(26-23(7-4-10-30-26)31-20-5-2-1-3-6-20)34-25-17-29-16-21(25)27-32-22-9-8-19(15-24(22)33-27)18-35-11-13-37-14-12-35;1-11-26-18(21(22,23)24)17(34-11)20(32)29-15-9-25-30-16(15)19-27-13-3-2-12(8-14(13)28-19)10-31-4-6-33-7-5-31/h1-11,16,18-19,31-32H,12-15,17,20H2,(H,33,34)(H,35,37);1,3-6,9-14,17-19,31H,2,7-8,15-16,20H2,(H,32,33)(H,34,36);1-10,15-17,29,31H,11-14,18H2,(H,32,33)(H,34,36);2-3,8-9H,4-7,10H2,1H3,(H,25,30)(H,27,28)(H,29,32)
InChIKeyKMBYLJKCSPRTGB-UHFFFAOYSA-N
MW1951.21 g/mol
LogP19.85
Rot. Bonds26

About 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide

3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide (PubChem CID 159174326) has the molecular formula C109H106F3N25O8 and a molecular weight of 1951.21 g/mol. Its IUPAC name is 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide.

Molecular Properties

Compound Name3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide
PubChem CID159174326
Molecular FormulaC109H106F3N25O8
Molecular Weight1951.21 g/mol
Exact Mass1949.86
IUPAC Name3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide
SMILESCc1nc(C(F)(F)F)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)o1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCCCC3)cc2[nH]1)c1ccccc1-c1ccccc1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccccc1NCc1ccccc1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ncccc1Nc1ccccc1
InChIInChI=1S/C30H30N6O2.C30H29N5O.C28H27N7O2.C21H20F3N7O3/c37-30(23-8-4-5-9-25(23)32-17-21-6-2-1-3-7-21)35-28-19-31-18-24(28)29-33-26-11-10-22(16-27(26)34-29)20-36-12-14-38-15-13-36;36-30(24-12-6-5-11-23(24)22-9-3-1-4-10-22)34-28-19-31-18-25(28)29-32-26-14-13-21(17-27(26)33-29)20-35-15-7-2-8-16-35;36-28(26-23(7-4-10-30-26)31-20-5-2-1-3-6-20)34-25-17-29-16-21(25)27-32-22-9-8-19(15-24(22)33-27)18-35-11-13-37-14-12-35;1-11-26-18(21(22,23)24)17(34-11)20(32)29-15-9-25-30-16(15)19-27-13-3-2-12(8-14(13)28-19)10-31-4-6-33-7-5-31/h1-11,16,18-19,31-32H,12-15,17,20H2,(H,33,34)(H,35,37);1,3-6,9-14,17-19,31H,2,7-8,15-16,20H2,(H,32,33)(H,34,36);1-10,15-17,29,31H,11-14,18H2,(H,32,33)(H,34,36);2-3,8-9H,4-7,10H2,1H3,(H,25,30)(H,27,28)(H,29,32)
InChIKeyKMBYLJKCSPRTGB-UHFFFAOYSA-N
XLogP19.85
TPSA410.80 Ų
H-Bond Donors14
H-Bond Acceptors21
Rotatable Bonds26
Heavy Atoms145
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001951.21
LogP ≤ 519.85
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1021

Analyze 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide?
The IUPAC name of 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide (CID 159174326) is 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide.
What is the SMILES notation for 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide?
The canonical SMILES for 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide is Cc1nc(C(F)(F)F)c(C(=O)Nc2cn[nH]c2-c2nc3ccc(CN4CCOCC4)cc3[nH]2)o1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCCCC3)cc2[nH]1)c1ccccc1-c1ccccc1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccccc1NCc1ccccc1.O=C(Nc1c[nH]cc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ncccc1Nc1ccccc1.
What is the InChIKey of 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide?
The InChIKey is KMBYLJKCSPRTGB-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H30N6O2.C30H29N5O.C28H27N7O2.C21H20F3N7O3/c37-30(23-8-4-5-9-25(23)32-17-21-6-2-1-3-7-21)35-28-19-31-18-24(28)29-33-26-11-10-22(16-27(26)34-29)20-36-12-14-38-15-13-36;36-30(24-12-6-5-11-23(24)22-9-3-1-4-10-22)34-28-19-31-18-25(28)29-32-26-14-13-21(17-27(26)33-29)20-35-15-7-2-8-16-35;36-28(26-23(7-4-10-30-26)31-20-5-2-1-3-6-20)34-25-17-29-16-21(25)27-32-22-9-8-19(15-24(22)33-27)18-35-11-13-37-14-12-35;1-11-26-18(21(22,23)24)17(34-11)20(32)29-15-9-25-30-16(15)19-27-13-3-2-12(8-14(13)28-19)10-31-4-6-33-7-5-31/h1-11,16,18-19,31-32H,12-15,17,20H2,(H,33,34)(H,35,37);1,3-6,9-14,17-19,31H,2,7-8,15-16,20H2,(H,32,33)(H,34,36);1-10,15-17,29,31H,11-14,18H2,(H,32,33)(H,34,36);2-3,8-9H,4-7,10H2,1H3,(H,25,30)(H,27,28)(H,29,32).
What are the key properties of 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide?
3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide has a molecular weight of 1951.21 g/mol, XLogP of 19.85, 26 rotatable bonds, 14 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide is sourced from PubChem (CID 159174326), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).